Industry Newsroom

Centurium-Led Consortium Completes USD4.76b Take-Private of China Biologics

A consortium of investors led by Centurium Capital and including CITIC Capital, Hillhouse Capital and Temasek has completed a take-private of China Biologic Products Holdings, a China-based producer of plasma-based biopharmaceuticals, valuing the company at a reported USD4.76b. Read more